Clinical trials
Imaging clinical trials
Below are recruiting imaging clinical trials, each written for real people, not researchers. We’re tracking 2,164 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06275022Recruiting
Using ICG dye to guide treatment of facial birthmarks
This study tests whether a special dye called ICG can help doctors treat a type of facial birthmark called capillary lymphatic malformation (cLM) more effectively. It may help by showing the birthmark more clearly during treatment.
Nanjing, JiangsuAges 4 weeks–16 years - NCT06265272Recruiting
PSMA-11 PET/MRI for Liver Cirrhosis
This study uses a special PET/MRI scan with a tracer called PSMA-11 to look at how liver cirrhosis affects the liver. It may help doctors better understand and monitor the disease.
Charlestown, MassachusettsAges 18–99 - NCT06266416Recruiting
Black caregivers & girls empowerment study
This study tests a program called IMARA to support black male caregivers and the girls they care for. It aims to improve family relationships and reduce risky behaviors in girls.
Chicago, IllinoisAges 13 years+ - NCT06262139RecruitingPhase 1/Phase 2
New MRI dye for high-risk prostate cancer
This trial tests a new MRI contrast dye that might help doctors see aggressive prostate cancer more clearly. It is for men with high-risk prostate cancer (Gleason 8-10) who have already had an MRI and a biopsy.
Atlanta, GeorgiaAges 18–90 - NCT06243783Recruiting
Stress and Brain Energy: A Healthy Volunteer Study
This study looks at how stress affects your brain's energy use. It involves an MRI scan and is for healthy, right-handed adults aged 18–40.
ViennaAges 18–40 - NCT06249191RecruitingPhase 1/Phase 2
Mosunetuzumab plus chemo for untreated high-grade B-cell lymphoma
This trial tests adding a drug called mosunetuzumab to standard chemotherapy for people with certain aggressive B-cell lymphomas. It aims to see if the combination works better than chemo alone.
Portland, OregonAges 18–75 - NCT06236139RecruitingPhase 1/Phase 2
Immune cells plus hormone therapy for advanced prostate cancer
This study tests a new type of treatment that uses your own immune cells (engineered to target prostate cancer) combined with a hormone therapy drug. It is for men with advanced prostate cancer that has stopped responding to standard hormone treatments.
Seattle, WashingtonAges 18 years+ - NCT06249282RecruitingPhase 1
Carfilzomib and sotorasib for KRAS G12C lung cancer
This trial tests a combination of two drugs: carfilzomib and sotorasib, for people with a specific type of advanced lung cancer (KRAS G12C mutation) who have already tried a KRAS-targeting drug that stopped working. The goal is to see if this new combination can shrink tumors or slow the cancer.
Duarte, CaliforniaAges 18 years+ - NCT06246942Recruiting
Understanding brain connections in healthy adults
This study uses brain scans to learn how different parts of the brain connect and communicate in healthy people. If you join, you will help researchers better understand normal brain function.
Boston, MassachusettsAges 18–64 - NCT06252493Recruiting
PET/MR scan for Crohn's disease scar tissue
This study is testing a new imaging method that uses a special PET/MR scan to see how active Crohn's disease is in your bowel. The scan uses a harmless radioactive tracer that attaches to scar tissue, which may help doctors better understand the disease and guide treatment.
Charlestown, MassachusettsAges 18–99 - NCT06247449Recruiting
MRI screening for brain metastases in aggressive breast cancer
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
Toronto, OntarioAges 18 years+ - NCT06244472Recruiting
New brain scanner for fast brain imaging
This study uses a new type of brain scanner (MEG) to take very fast pictures of brain activity. It's for healthy people or those who've had a mild concussion recently.
BronAges 18–70 - NCT04569149Recruiting
Registry for very small-bodied, low-head-growth syndromes
This is a registry (a secure list of patients) for people with rare conditions that cause very small size and a smaller-than-usual head from early life. It helps researchers learn more about these conditions and how they vary from person to person.
Wilmington, DelawareAges Any age - NCT06223542RecruitingPhase 1
TAK-243 for advanced cancers that haven't responded to other treatments
This trial tests a new drug called TAK-243 for people with advanced cancers (solid tumors or lymphomas) that have not responded to other treatments. It aims to see if the drug is safe and how well it works.
Bethesda, MarylandAges 18 years+ - NCT04658628Recruiting
Brain scan study to learn who responds to spinal cord stimulation
This trial uses brain imaging to understand which people with long-lasting low back pain are more likely to benefit from spinal cord stimulation (SCS). If you’re being considered for an SCS trial, the scans may help researchers predict response and improve future care.
Los Angeles, CaliforniaAges 21 years+ - NCT04662970Recruiting
Imaging after a heart device to optimize pacing settings
This study uses a heart MRI (a special scan) to better map the heart’s electrical activity, with the goal of fine-tuning settings on your implanted pacing device. It’s meant to improve how well the device coordinates your heartbeat.
Innsbruck, TyrolAges 18 years+ - NCT06207188Recruiting
Using sound waves to tell thyroid lumps apart
This study uses a special ultrasound technique to look at thyroid nodules and lumps in the neck. The goal is to tell the difference between harmless lumps and cancer, so you may get a clearer answer without extra procedures.
Scottsdale, ArizonaAges 8 years+ - NCT06210555Recruiting
MRI Study of Kidney Donors, Recipients, and Healthy People
This study uses advanced MRI scans to look at kidney health in living donors, transplant recipients, and healthy people. It aims to find links between MRI results and kidney function, fibrosis (scarring), and aging.
Aarhus, Central JutlandAges 18–80 - NCT06220396Recruiting
Heart and Metabolism in Healthy Adults (CAMERA Study)
This study looks at how the heart and metabolism work together during exercise in healthy adults. It uses special tests (including a heart catheterization during exercise and an MRI) to understand normal heart function and reserve capacity.
Rochester, MinnesotaAges 30 years+ - NCT06225427RecruitingPhase 1
Gilteritinib for advanced ALK-positive lung cancer
This trial tests a drug called gilteritinib for people with a specific genetic type of lung cancer (ALK-positive) that has spread and has been treated before. You may be eligible if you have already tried at least one targeted therapy, and your cancer is still growing.
Los Angeles, CaliforniaAges 18 years+ - NCT06218381Recruiting
Brief exposure for PTSD in combat veterans
This study tests a very brief exposure therapy to help U.S. combat veterans with PTSD. It is designed for veterans who have not had recent mental health treatment and experienced combat trauma within the last 10 years.
Los Angeles, CaliforniaAges 18–50 - NCT06203600RecruitingPhase 2/Phase 3
Nivolumab plus standard treatment for advanced stomach or esophageal cancer
This trial tests whether adding the immunotherapy drug nivolumab to standard treatment works better for advanced stomach or esophageal cancer. It is for people whose cancer has already progressed after a first round of chemo plus immunotherapy.
Little Rock, ArkansasAges 18 years+ - NCT06202235Recruiting
Magnetic resonance imaging for chronic kidney disease
This trial uses a special MRI technique called multifrequency magnetic resonance elastography (MRE) to see if it can help evaluate chronic kidney disease. It may provide a non-invasive way to monitor kidney health without needing a biopsy.
Shenyang, LiaoningAges 18–65 - NCT06182683Recruiting
OCT-Guided vs. FFR-Guided Stent Placement in Heart Disease
This trial compares two imaging and pressure tests used during stent placement to see which helps improve blood flow better in people with chest pain or a recent heart attack.
SeoulAges 19 years+
Hear when a new Imaging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for imaging?
- Yes. Clin2 currently lists 2,164 recruiting imaging studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a imaging trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a imaging trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.